REVIVICOR
Revivicor is a regenerative medicine company focused on applying leading-edge animal biotechnology platforms to provide a superior quality, high-volume, human-compatible, alternative tissue source for treatment of human degenerative disease.
REVIVICOR
Industry:
Biotechnology
Founded:
2003-01-01
Address:
Blacksburg, Virginia, United States
Country:
United States
Website Url:
http://www.revivicor.com
Status:
Active
Contact:
(540)961-5559
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS ASP.NET IIS
Similar Organizations
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Current Employees Featured
Founder
Official Site Inspections
http://www.revivicor.com Semrush global rank: 3.64 M Semrush visits lastest month: 3.91 K
- Host name: 45.60.45.59
- IP address: 45.60.45.59
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Revivicor"
Revivicor, A United Therapeutics Company | Revivicor
Revivicor's vision is to provide organs from gene-edited pigs to overcome the critical shortage of human organs for transplant.See details»
Technologies - Revivicor
Revivicor will raise organ donor pigs in a designated pathogen-free facility to eliminate microorganisms that could transmit disease to human transplant recipients. Xenohearts are …See details»
Meet some of the pigs raised to grow kidneys and …
Jul 21, 2024 · After decades of failed attempts, companies including Revivicor, eGenesis and Makana Therapeutics are engineering pigs to be more humanlike. So far in the U.S. there have been four “compassionate use” transplants, last …See details»
Revivicor - Crunchbase Company Profile & Funding
Revivicor is a regenerative medicine company focused on applying leading-edge animal biotechnology platforms to provide a superior quality, high-volume, human-compatible, alternative tissue source for treatment of human …See details»
Genetically modified pigs could provide unlimited …
Feb 29, 2024 · Revivicor hopes that will provide the data to get the modified pig organs approved by the Food and Drug Administration. Ethical concerns temper hope But the prospect of using animal organs for ...See details»
Revivicor Company Profile 2024: Valuation, Investors, Acquisition ...
Provider of regenerative medicines focused on providing organs from gene-edited pigs to overcome the critical shortage of human organs for transplant. The company's …See details»
Genetically Modified Porcine-to-Human Cardiac …
Jun 22, 2022 · The request to the FDA was for the combined use of a 10-gene-edit pig donor (Revivicor), a humanized anti-CD40 monoclonal antibody (Kiniksa Pharmaceuticals), and an XVIVO heart perfusion system...See details»
First pig heart transplant for humans occurred in …
Dec 19, 2023 · In a parallel development, surgeons have transplanted kidneys from Revivicor pigs into multiple brain-dead patients, with one set functioning for 61 days in a study that ended on Sept. 13, according to Revivicor’s parent …See details»
First GM pigs for allergies. Could xenotransplants be next?
Apr 12, 2021 · Revivicor, now a subsidiary of United Therapeutics, is still angling to transplant pig kidneys and hearts into human patients—just not with GalSafe-derived organs.See details»
Publications - Revivicor
Jan 28, 2024 · Revivicor's vision is to provide organs from gene-edited pigs to overcome the critical shortage of human organs for transplant.See details»
Revivicor - Biotech Careers
Revivicor Inc. is a regenerative medicine company focused on applying animal biotechnology platforms to provide high-volume, human-compatible, alternative tissue source for treating …See details»
Revivicor - Products, Competitors, Financials, Employees, …
Revivicor's vision is the commercialization of therapies that can treat and cure serious human disease through regenerative medicine; namely, the replacement of cells, tissues, and organs. …See details»
Revivicor’s $100 million pig-organ facility moves forward
Aug 30, 2023 · By early next year, Blacksburg-based Revivicor will be raising genetically modified pigs in Montgomery County, with plans to harvest their hearts and kidneys for …See details»
Meet The New Biotech Billionaire Putting Pig Hearts In Humans
Jul 18, 2024 · United Therapeutics acquired xenotransplantation tech firm Revivicor (which created the first cloned mammal, Dolly the sheep) to develop organs raised in pigs.See details»
First gene-edited pig kidney transplant | Nature Biotechnology
Apr 17, 2024 · In recent years, the first person to receive a genetically edited pig heart from the company Revivicor, a subsidiary of United Therapeutics, lived for two months; a second …See details»
Revivicor, Inc. Company Profile | Blacksburg, VA | Competitors ...
Find company research, competitor information, contact details & financial data for Revivicor, Inc. of Blacksburg, VA. Get the latest business insights from Dun & Bradstreet.See details»
How genetically modified pigs could end the shortage of organs …
Feb 29, 2024 · At the end of the drive, I meet David Ayares, who runs Revivicor Inc., a biotech company based in Blacksburg, Virginia.See details»
Last week, a person got a pig heart—here’s the firm ... - Tech Brew
Jan 12, 2022 · Revivicor is owned by biotech firm United Therapeutics, which purchased it for $7.6 million in 2011. In 2003, Revivicor was spun out from PPL Therapeutics—a UK-based …See details»
Startup looks to begin pig-to-human organ transplants by 2022
Jan 7, 2021 · A company called Revivicor has received clearance from the FDA to use their genetically modified pigs for medical use or as food. The pigs lack genes for alpha-gal sugar, …See details»
Revivicor: How to Invest in the Pig Heart Transplant Company
Jan 12, 2022 · Revivicor: How to Invest in the Pig Heart Transplant Company. Revivicor has done the first-ever successful pig heart transplant on a human being. Does the company have stock …See details»